Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer | BMC Cancer | Full Text

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer | BMC Cancer | Full Text

Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer

Adjuvant gemcitabine for pancreatic cancer has limited efficacy in the clinical setting. Impaired drug metabolism is associated with treatment resistance. We aimed to evaluate the chemosensitising effect of in...

Authors:Amber Blaauboer, Stephanie Booy, Peter M. van Koetsveld, Bas Karels, Fadime Dogan, Suzanne van Zwienen, Casper H. J. van Eijck and Leo J. Hofland

Citation:BMC Cancer 2020 20:913

Content type:Research article

 

Published on: 23 September 2020

• ViewFull Text
 
• ViewPDF